Access detailed search options for content from the Clinical Journal of Oncology Nursing & Oncology Nursing Forum below.
In this interactive case study, you will prepare for a tumor board discussion that will determine whether your patient is a candidate for biomarker testing and eligible for biomarker-directed therapy.
Explains the mechanism of action or CDK4/6 inhibitor, a targeted therapy used in the treatment of HR+, HER2- metastatic breast cancer.
After your patient is prescribed a CDK4/6 inhibitor, use this video to ensure that you have completed the appropriate initial assessment and tests.
Learn what to assess for prior to starting an oral agent and the signs of non-adherence.
As the use of CAR T-Cell therapy grows, understanding the events involved, the adverse events associated with this therapy and evidence-based management strategies is critical. Use this resource to enhance your understanding of the process behind CAR T-Cell therapy and nursing considerations associated with the treatment.
Paired somatic and germline testing is simultaneous genomic sequencing of a somatic and germline sample from a patient to inform cancer treatment.
Follow a nurse through assessment and early interventions to better understand cytokine release syndrome, an adverse reaction associated with Car T-Cell therapy.
Apply the biomarker testing nursing process to your practice to guide the delivery of genomic care to all patients with cancer.